CTS implements Ortho VIP Viral Marker Testing Platform

25Jan

CTS implements Ortho VIP Viral Marker Testing Platform

25 Jan, 2021 | Return|

On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the Prism to the VIP is one of the most significant changes we have made in the past three years. We implemented the new system through the dedication and extraordinary effort of everyone across the enterprise. Congratulations on this important success!

CTS Dallas Implements New Laboratory Information System

O'Dina Hurlburt | 0 Comments

On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...

FDA Updates Emergency Use Authorization for COVID-19 Convalescent Plasma

Lindsey Houghton | 0 Comments

On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...

CTS Charlotte Implements New Laboratory Information System

O'Dina Hurlburt | 0 Comments

On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...

COVID-19 Antibody Testing Frequently Asked Questions

Lindsey Houghton | 0 Comments

The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...

FDA Releases ZIKV Guidance and Grifols ZIKV Assay Licensed- 1st Update

O'Dina Hurlburt | 0 Comments

This is the first update to the original CTS communication distributed on July 6th. As previously co...

National Blood Donor Month

O'Dina Hurlburt | 0 Comments

Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...

Articles